Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Home Depot, Inc. (HD), Lowe’s Companies, Inc. (LOW): Two Hardline Stocks to Buy on a Housing Recovery

Page 1 of 2

As a segment, home improvement had the highest expectations among hardliners. Housing data points were largely supportive during Q1 and the market got more comfortable with the idea that the recovery is real and is gaining steam. But supplier commentary was somewhat mixed with outdoor-related categories weaker. Who is right: housing data or suppliers?

How did the hardliners perform?

The Home Depot, Inc. (NYSE:HD)

The Home Depot, Inc. (NYSE:HD), a well-known supplier of home-decoration products, has been a pure play on the performance of the housing market. The company delivered a solid Q1 beat, especially considering the unfavorable weather in many markets. Managing through difficult weather comparisons, the company prudently controlled expenses to drive 132 bps of EBIT expansion and produced solid 28% EPS growth on a year-over-year basis.

Despite the fact that The Home Depot, Inc. (NYSE:HD)’s comp of 4.3% decelerated sequentially by 260 bps on a two-year stack, the company’s top line is expected to accelerate throughout 2013 given its strong internal momentum and a developing external tailwind in housing. Home Depot raised full-year guidance from 3% to 4% (growth in revenue), and the EPS guidance was raised by $0.15, or 4.5%. Moreover, in the conference call management claimed that the company’s comps accelerated in April after a difficult March.

On an overall note, as the year progresses we should see improving results from The Home Depot, Inc. (NYSE:HD). The company is a well-managed, best-in-class retailer whose cyclical tailwinds have yet to be fully realized. Any sales headwind that the weather presented in select categories (e.g., gardening) should be recouped, not lost. The external tailwinds in housing and Hurricane Sandy rebuilding efforts remain. Moreover, Home Depot is expected to continue to aggressively return capital to its shareholders through share repurchases and dividends.

Home Depot vs. another player

Results for Lowe’s Companies, Inc. (NYSE:LOW) were pretty much in line with the consensus estimates, but continue to trail Home Depot. That was expected as The Home Depot, Inc. (NYSE:HD) is executing better, catching up in appliances, has more Sandy exposure, and has more exposure in recovering markets. It is not important for the company to narrow the comp gap; what is important is for Lowe’s is to show progress toward its 3.5% comp goal for the year, and to do that while improving the gross margin. If there was an item of concern in the quarter, it was gross margin, as the company failed to meet the Street’s estimate (which was an expected rise of more than 10 bps in the margin).

To date, management has made important progress on end caps, product-line reviews, resetting key parts of the store and moving to ‘everyday low prices guaranteed.’ These efforts do not come without pain, as one can ask Ron Johnson (former CEO of J.C. Penney Company, Inc. (NYSE:JCP)), and the benefits do not always occur in a straight line. The Street continues to like the setup going forward.

What is the setup? Some 28% of the stock is projected to be repurchased over the next three years. Moreover, housing and weather are likely to give strong tailwinds to results beginning in Q2. Many of the initiatives that Lowe’s Companies, Inc. (NYSE:LOW) is investing in will take time to pay off, but they will pay off eventually. A major competitor is reducing its footprint in the space and of course, the cicadas are beginning to emerge. In a press release, the management discussed improved results in April and May, as expected, and commentary on this strength and support for a higher gross margin should continue to send the stock higher.

On an overall note, this stock has been, and should remain, rockier than the orange-blooded competitor, but there is no reason to believe that there can’t be two winners in this space.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!